• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢病毒介导的 SIVA-1 过表达逆转了胃癌细胞系对顺铂的耐药性。

Lentivirus-Mediated Overexpression of SIVA-1 Reverses Cisplatin Resistance in Gastric Cancer in vitro.

机构信息

Department of Gastrointestinal and Peripheral Vascular Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Department of Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

出版信息

Cell Biochem Biophys. 2020 Dec;78(4):455-463. doi: 10.1007/s12013-020-00929-y. Epub 2020 Jul 9.

DOI:10.1007/s12013-020-00929-y
PMID:32648086
Abstract

SIVA-1 plays a critical role in the induction of apoptosis in a number of different cell lines and participates in the mechanism of cisplatin (DDP)-mediated antitumor effects. However, the involvement of SIVA-1 in cisplatin resistance in gastric carcinoma has not been revealed. To explore the effect of SIVA-1 on DDP resistance, a recombinant pGV358-GFP-SIVA-1 lentiviral vector was constructed and transfected into human cisplatin-resistant MKN45/DDP gastric cancer cells. Subsequently, stable SIVA-1 overexpression was established in MKN45/DDP cells, which resulted in increased DDP sensitivity in MKN45/DDP cells in vitro. Flow cytometry demonstrated that SIVA-1 overexpression increased the percentage of apoptotic cells compared to that in the control. The colony formation assay clearly revealed that cell growth and proliferation were significantly suppressed following SIVA-1 overexpression. In addition, overexpression of SIVA-1 inhibited the migratory and invasive potential of MKN45/DDP cells in vitro. Western blot analysis indicated that SIVA-1 increased the expression levels of p53, p73, and p14ARF, whereas it reduced Bcl-2, MDM2, and Bcl-xL expression. In short, SIVA-1 upregulated the protein expression of p53, p73, and p14ARF and decreased that of Bcl-2, MDM2, and Bcl-xL in vitro and subsequently reversed cisplatin resistance in gastric cancer cells, suggesting that SIVA-1 serves as a valuable potential target for attenuating chemotherapy resistance.

摘要

SIVA-1 在许多不同的细胞系中诱导细胞凋亡中发挥关键作用,并参与顺铂(DDP)介导的抗肿瘤作用的机制。然而,SIVA-1 参与胃癌顺铂耐药性尚未被揭示。为了探讨 SIVA-1 对 DDP 耐药性的影响,构建了重组 pGV358-GFP-SIVA-1 慢病毒载体,并转染人顺铂耐药 MKN45/DDP 胃癌细胞。随后,在 MKN45/DDP 细胞中建立了稳定的 SIVA-1 过表达,导致 MKN45/DDP 细胞对 DDP 的敏感性增加。流式细胞术表明,与对照组相比,SIVA-1 过表达增加了凋亡细胞的百分比。集落形成实验清楚地表明,SIVA-1 过表达后细胞生长和增殖明显受到抑制。此外,SIVA-1 过表达抑制了 MKN45/DDP 细胞在体外的迁移和侵袭能力。Western blot 分析表明,SIVA-1 增加了 p53、p73 和 p14ARF 的表达水平,而降低了 Bcl-2、MDM2 和 Bcl-xL 的表达。总之,SIVA-1 上调了 p53、p73 和 p14ARF 的蛋白表达,下调了 Bcl-2、MDM2 和 Bcl-xL 的表达,在体外逆转了胃癌细胞的顺铂耐药性,表明 SIVA-1 可能成为减轻化疗耐药性的有价值的潜在靶点。

相似文献

1
Lentivirus-Mediated Overexpression of SIVA-1 Reverses Cisplatin Resistance in Gastric Cancer in vitro.慢病毒介导的 SIVA-1 过表达逆转了胃癌细胞系对顺铂的耐药性。
Cell Biochem Biophys. 2020 Dec;78(4):455-463. doi: 10.1007/s12013-020-00929-y. Epub 2020 Jul 9.
2
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.Mdm2 抑制通过激活 p73 和 E2F1 介导的 PUMA 和 Siva-1 的表达诱导 p53 缺陷型人结肠癌细胞凋亡。
Apoptosis. 2011 Jan;16(1):35-44. doi: 10.1007/s10495-010-0538-0.
3
Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on and experiments.基于 和 实验研究疣螈与顺铂联用降低胃癌化疗耐药性的机制。
Aging (Albany NY). 2024 Feb 9;16(4):3386-3403. doi: 10.18632/aging.205540.
4
The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.p53 上调凋亡调节剂(PUMA)通过降低 Bcl-x(L) 和 Mcl-1 设置的阈值使顺铂对内在耐药的卵巢癌细胞增敏。
Mol Med. 2011;17(11-12):1262-74. doi: 10.2119/molmed.2011.00176. Epub 2011 Aug 19.
5
Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.慢病毒介导的靶向ERCC1的RNA干扰沉默可逆转顺铂耐药卵巢癌细胞系的顺铂耐药性。
DNA Cell Biol. 2015 Jul;34(7):497-502. doi: 10.1089/dna.2015.2805. Epub 2015 May 5.
6
Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.鸡豆黄素通过增强 Bax 和 BOK 的表达逆转人胃癌的多药耐药性。
Biomed Pharmacother. 2018 Jul;103:67-74. doi: 10.1016/j.biopha.2018.03.110. Epub 2018 Apr 7.
7
HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.HZ08 通过调节 p53 通路逆转胃癌中顺铂诱导的非整倍体耐药性。
Eur J Pharmacol. 2013 Nov 15;720(1-3):84-97. doi: 10.1016/j.ejphar.2013.10.045. Epub 2013 Oct 29.
8
LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.长链非编码RNA SNHG5通过抑制细胞凋亡促进胃癌顺铂耐药。
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4185-4191. doi: 10.26355/eurrev_201905_17921.
9
Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.p73基因过表达对人肺腺癌细胞系A549凋亡及化疗敏感性的影响
Ai Zheng. 2006 Aug;25(8):925-32.
10
[Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].[E2F-1基因沉默逆转人胃癌SGC7901/DDP细胞的多药耐药性]
Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):171-6.

引用本文的文献

1
The Role of Glutamatergic Neurons in Changes of Synaptic Plasticity Induced by THz Waves.谷氨酸能神经元在太赫兹波诱导的突触可塑性变化中的作用。
Biomolecules. 2025 Apr 4;15(4):532. doi: 10.3390/biom15040532.
2
SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth .SIVA-1与PCBP1的相互作用作为胃癌顺铂敏感性的预测生物标志物及其对肿瘤生长的抑制作用。
J Cancer. 2024 Jun 11;15(13):4301-4312. doi: 10.7150/jca.92963. eCollection 2024.
3
SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway.

本文引用的文献

1
Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene.Siva-1不仅作为一种促凋亡基因发挥其经典作用,还作为一种组织特异性癌基因出现。
Onco Targets Ther. 2018 Oct 1;11:6361-6367. doi: 10.2147/OTT.S173001. eCollection 2018.
2
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy.急性髓系白血病中Bcl-2抑制与p53激活联合作用的合成致死性:机制与卓越的抗白血病疗效
Cancer Cell. 2017 Dec 11;32(6):748-760.e6. doi: 10.1016/j.ccell.2017.11.003.
3
Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials.
SIVA-1通过调节ARF/MDM2/p53通路增强胃癌在体内获得性化疗耐药性。
Heliyon. 2024 Jan 11;10(2):e24394. doi: 10.1016/j.heliyon.2024.e24394. eCollection 2024 Jan 30.
关于可切除胃癌术后化疗的研究有效性:随机试验的批判性评价
BMJ Open Gastroenterol. 2017 Sep 14;4(1):e000138. doi: 10.1136/bmjgast-2017-000138. eCollection 2017.
4
p53, p63 and p73 in the wonderland of .处于……奇妙世界中的p53、p63和p73 。 你提供的原文似乎不完整,“in the wonderland of.”后面应该还有内容。
Oncotarget. 2017 Jun 16;8(34):57855-57869. doi: 10.18632/oncotarget.18506. eCollection 2017 Aug 22.
5
Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.Siva 1通过磷酸化卵巢癌细胞中的Stathmin来抑制细胞增殖、迁移和侵袭。
Oncol Lett. 2017 Aug;14(2):1512-1518. doi: 10.3892/ol.2017.6307. Epub 2017 Jun 2.
6
Molecular mechanisms of chemoresistance in gastric cancer.胃癌化疗耐药的分子机制
World J Gastrointest Oncol. 2016 Sep 15;8(9):673-81. doi: 10.4251/wjgo.v8.i9.673.
7
Erratum to: Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.《多西他赛、顺铂和 S-1(DCS)化疗对无法手术的晚期胃癌患者的转化治疗:一项多机构回顾性研究》勘误
Gastric Cancer. 2017 May;20(3):527. doi: 10.1007/s10120-016-0643-z.
8
Bcl-2 family proteins: master regulators of cell survival.Bcl-2家族蛋白:细胞存活的主要调节因子。
Biomol Concepts. 2016 Aug 1;7(4):259-70. doi: 10.1515/bmc-2016-0015.
9
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
10
Cisplatin resistance and opportunities for precision medicine.顺铂耐药性与精准医学的机遇
Pharmacol Res. 2016 Apr;106:27-36. doi: 10.1016/j.phrs.2016.01.001. Epub 2016 Jan 22.